Halozyme raises $62.3 million

Halozyme Therapeutics Inc. (NASDAQ:HALO) raised $62.3 million through the sale of 8.3 million shares at $7.50 in a follow-on underwritten by Barclays Capital. Halozyme proposed the offering late Wednesday, when its share price was $7.99. Halozyme was off $0.40 to $7.59 on Thursday. ...